RSLBF.US RaySearch Laboratories AB (publ)

Healthcare Health Care Technology USA Stocks
22.34 USD
Close of Nov 9, 2026
16.49 25.03
Market cap
USD 666M
P/E
31.3x
P/B
8.25x
ROE
21.8%
Dividend yield
2.13%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is RSLBF.US undervalued?

Graham number

The Graham number of RaySearch Laboratories AB (publ) cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RaySearch Laboratories AB (publ) fundamental analysis

No fundamental analysis for RaySearch Laboratories AB (publ) yet.

RaySearch Laboratories AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning a…

Full company profile